BIOMAT Database Logo BIOMAT Database Logo

[The endocrine profile in prostatic cancer: therapeutic implications]. 1981

M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega

UI MeSH Term Description Entries
D007016 Hypophysectomy Surgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed) Hypophysectomies
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen

Related Publications

M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Prostatic cancer: endocrine treatment.
January 1984, The Turkish journal of pediatrics,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Endocrine-control therapy in prostatic cancer.
December 1958, British journal of urology,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
[Endocrine chemotherapy for prostatic cancer].
June 1994, Hinyokika kiyo. Acta urologica Japonica,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
[Endocrine therapy for prostatic cancer ].
April 1982, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
ENDOCRINE CONTROL OF PROSTATIC CANCER.
June 1943, Science (New York, N.Y.),
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
[ENDOCRINE TREATMENT OF PROSTATIC CANCER].
January 1963, Jaarboek van kankeronderzoek en kankerbestrijding in Nederland. Yearbook for cancer research and fight against cancer in the Netherlands,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Endocrine treatment of prostatic cancer.
March 1986, Journal of the Royal Society of Medicine,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Endocrine treatment of prostatic cancer.
June 1983, Urology,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Endocrine treatment of prostatic cancer.
February 1984, Urology,
M A Calvo Mateo, and J M Castellanos Llorens, and A Galán Ortega
Endocrine treatment of prostatic cancer.
October 1985, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!